Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

November 1, 2005

Maximizing margin's meaning for melanoma

Atlanta — Recent developments in melanocyte-specific immunohistochemical stains are again proving that this technology, along with the proper technique, can enhance sensitivity in differentiating malignant melanoma from nevi in diagnostic specimens as well as in the interpretation of Mohs margins, according to Dirk M. Elston, M.D., here at the American Society for Dermatologic Surgery — American College of Mohs Micrographic Surgery and Cutaneous Oncology combined annual meeting.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!